CK Life Sciences Int'l., (Holdings) Inc.

0775.HK

0775.HKCK Life Sciences Int'l., (Holdings) Inc. HK flag

Hong Kong Stock Exchange

0.79

HKD

-0.01

(-1.27%)

-0.01EPS

-79.00P/E

7.59BMarket Cap

Mar 18Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

CK Life Sciences Int'l., (Holdings) Inc.

0775.HK

(Hong Kong Stock Exchange)

Recent

price

0.79

P/E

ratio

-79

div

yld

- -

ROIC.AI

Legends:

Stock price

Beta (1.0 Market)

% total return 04/22

Stock

S&P500

132.35

6.57

25.40

22.75

-25.47

93.55

2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
0.28	0.28	0.37	0.47	0.52	0.52	0.51	0.51	0.49	0.54	0.52	0.51	0.56	0.55	0.55	0.57	Revenue per Share
0.02	0.02	0.01	0.02	0.02	0.03	0.02	0.03	0.03	0.03	0.02	0.01	0.02	0.01	- -	-0.01	Basic EPS, GAAP
0.01	- -	- -	0.04	0.01	0.02	- -	0.02	- -	-0.01	0.02	0.02	0.02	0.02	0.02	0.02	Free Cash Flow per Basic Share
- -	- -	- -	- -	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	- -	Dividend per Share
0.08	0.1	0.11	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.31	0.33	0.34	0.34	0.33	Book Value per Share
0.11	0.17	0.16	0.15	0.12	0.11	0.07	0.09	0.12	0.09	0.06	0.1	0.09	0.06	0.06	0.01	Tangible Book Value per Share
9,611	9,611	9,611	9,611	9,611	9,611	9,611	9,611	9,611	9,611	9,611	9,611	9,611	9,611	9,611	9,611	Basic Weighted Avg Shares
2,679	2,694	3,512	4,545	4,971	4,954	4,919	4,869	4,693	5,233	4,967	4,943	5,402	5,276	5,323	5,523	Sales/Revenue/Turnover
27.59	25.29	7.41	8.77	6.46	6.27	5.66	6.51	3.23	7.31	5.63	1.71	4.46	4.59	4.21	1.4	Operating Margin (%)
108	95	102	104	136	136	155	135	145	138	204	220	247	231	234	245	Depreciation Expense
187	209	126	176	229	264	219	253	258	263	182	125	163	132	17	-127	Net Income, GAAP
13.59	11.41	28.66	34.21	22.78	15.06	25.42	26.22	14.98	28.62	12.64	- -	31.66	35.59	74.85	- -	Effective Tax Rate (%)
6.98	7.74	3.58	3.88	4.61	5.32	4.45	5.2	5.51	5.03	3.66	2.53	3.01	2.5	0.32	-2.29	Profit Margin (%)
1,341	473	1,263	1,252	671	1,858	474	-1,216	1,190	1,309	-529	2,376	1,094	-937	892	652	Working Capital
1,096	37	2,229	2,357	2,761	4,229	2,760	925	3,403	3,893	2,773	6,117	4,920	2,820	4,709	4,749	LT Debt
5,077	5,622	5,633	5,724	5,200	4,875	4,209	4,403	4,757	4,420	4,175	4,718	4,501	4,155	4,189	3,512	Total Equity
10.91	9.27	2.53	3.24	2.87	2.88	2.34	2.75	1.44	2.92	2.55	- -	1.52	1.49	0.56	- -	Return on Invested Capital (%)
10.84	11.19	6.98	5.85	7	6.62	6.09	5.93	5.84	5.47	4.99	- -	2.48	2.55	1.07	- -	Return on Capital (%)
28.87	24.63	12.4	17.3	23.83	27.42	22.77	26.32	26.89	27.36	18.91	6.35	5.31	4.11	0.52	-3.91	Return on Common Equity (%)

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	1.22%	2.22%	3.76%
Net Income, GAAP	-96.9%	-188.12%	-833.65%
Free Cash Flow	-38.74%	2.36%	-30.71%
Total Cash Common Dividend	- -	- -	- -
Total Equity	-2.83%	-2.93%	-16.18%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Similar Companies: Zhaoke Ophthalmology Limited (6622.HK)
Wave Life Sciences Ltd. (WVE)
Shanghai Junshi Biosciences Co., Ltd. (1877.HK)
ImmunityBio, Inc. (IBRX)
Keros Therapeutics, Inc. (KROS)
Forward Pharma A/S (FWP)
Business: CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, markets, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products for the home gardening market; and produces non-sterile prescription and over-the-counter medicines. The company is also involved in the contract manufacturing of complementary healthcare medicines, pharmaceutical products, and cosmetics; licensing of registration activities and the importation of finished agricultural goods; holding of land and buildings; financing activities; investment in financial instruments and vineyards; trading of biotechnology products and nutritional supplements; and manufacturing, wholesaling, retailing, and distribution of nutraceutical products. In addition, it distributes turf management machinery, hardware, equipment, and accessories, as well as turf fertilizers, chemicals, and professional pest products; produces, refines, and distributes salt products; and provides research and development services for biotechnology and life sciences technology products. Further, it researches, develops, manufactures, and commercializes drug products to treat pain and melanoma; supplies raw materials for nutritional health, pharmaceutical, cosmetics, personal care, and food segments; and offers packing and asset management services. CK Life Sciences Int'l., (Holdings) Inc. was founded in 1999 and is headquartered in Tai Po, Hong Kong.


No results.


No results.

2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
0.28	0.28	0.37	0.47	0.52	0.52	0.51	0.51	0.49	0.54	0.52	0.51	0.56	0.55	0.55	0.57	Revenue per Share
0.02	0.02	0.01	0.02	0.02	0.03	0.02	0.03	0.03	0.03	0.02	0.01	0.02	0.01	- -	-0.01	Basic EPS, GAAP
0.01	- -	- -	0.04	0.01	0.02	- -	0.02	- -	-0.01	0.02	0.02	0.02	0.02	0.02	0.02	Free Cash Flow per Basic Share
- -	- -	- -	- -	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	- -	Dividend per Share
0.08	0.1	0.11	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.31	0.33	0.34	0.34	0.33	Book Value per Share
0.11	0.17	0.16	0.15	0.12	0.11	0.07	0.09	0.12	0.09	0.06	0.1	0.09	0.06	0.06	0.01	Tangible Book Value per Share
9,611	9,611	9,611	9,611	9,611	9,611	9,611	9,611	9,611	9,611	9,611	9,611	9,611	9,611	9,611	9,611	Basic Weighted Avg Shares
2,679	2,694	3,512	4,545	4,971	4,954	4,919	4,869	4,693	5,233	4,967	4,943	5,402	5,276	5,323	5,523	Sales/Revenue/Turnover
27.59	25.29	7.41	8.77	6.46	6.27	5.66	6.51	3.23	7.31	5.63	1.71	4.46	4.59	4.21	1.4	Operating Margin (%)
108	95	102	104	136	136	155	135	145	138	204	220	247	231	234	245	Depreciation Expense
187	209	126	176	229	264	219	253	258	263	182	125	163	132	17	-127	Net Income, GAAP
13.59	11.41	28.66	34.21	22.78	15.06	25.42	26.22	14.98	28.62	12.64	- -	31.66	35.59	74.85	- -	Effective Tax Rate (%)
6.98	7.74	3.58	3.88	4.61	5.32	4.45	5.2	5.51	5.03	3.66	2.53	3.01	2.5	0.32	-2.29	Profit Margin (%)
1,341	473	1,263	1,252	671	1,858	474	-1,216	1,190	1,309	-529	2,376	1,094	-937	892	652	Working Capital
1,096	37	2,229	2,357	2,761	4,229	2,760	925	3,403	3,893	2,773	6,117	4,920	2,820	4,709	4,749	LT Debt
5,077	5,622	5,633	5,724	5,200	4,875	4,209	4,403	4,757	4,420	4,175	4,718	4,501	4,155	4,189	3,512	Total Equity
10.91	9.27	2.53	3.24	2.87	2.88	2.34	2.75	1.44	2.92	2.55	- -	1.52	1.49	0.56	- -	Return on Invested Capital (%)
10.84	11.19	6.98	5.85	7	6.62	6.09	5.93	5.84	5.47	4.99	- -	2.48	2.55	1.07	- -	Return on Capital (%)
28.87	24.63	12.4	17.3	23.83	27.42	22.77	26.32	26.89	27.36	18.91	6.35	5.31	4.11	0.52	-3.91	Return on Common Equity (%)

CK Life Sciences Int'l., (Holdings) Inc.

Growth Rates

(avg. rate of change)

Capital Structure

Working Capital

Growth Rates

(avg. rate of change)

Quarterly Earnings Per Share

Year

Quarterly Revenue

Year

Quarterly Dividends Per Share

Year